ONTOLOGY REPORT - ANNOTATIONS
| Term: | phosphodiesterase inhibitor |
|
| Accession: | CHEBI:50218
|
browse the term
|
| Definition: | Compound which inhibits or antagonizes the biosynthesis or actions of phosphodiesterases. |
| Synonyms: | related_synonym: | phosphodiesterase inhibitors |
|
|
caffeine
|
| G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
|
decreases expression |
ISO |
1 |
41,922,020 |
41,940,074 |
RGD:6480464 |
CTD |
| G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
|
increases expression |
ISO |
15 |
32,719,863 |
32,764,748 |
RGD:6480464 |
CTD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
increases expression |
ISO |
9 |
78,083,239 |
78,106,933 |
RGD:6480464 |
CTD |
| G |
Actr1a |
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) |
|
multiple interactions |
ISO |
1 |
251,592,429 |
251,611,097 |
RGD:6480464 |
CTD |
| G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
|
decreases expression |
EXP |
20 |
11,616,718 |
11,747,294 |
RGD:6480464 |
CTD |
| G |
Adck3 |
aarF domain containing kinase 3 |
|
multiple interactions |
ISO |
13 |
95,869,376 |
95,896,742 |
RGD:6480464 |
CTD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
multiple interactions |
ISO |
19 |
20,051,639 |
20,073,861 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
increases expression |
EXP |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
decreases activity |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
decreases expression |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
ISO |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
increases expression |
ISO |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
decreases activity |
ISO |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
increases response to substance |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
affects response to substance |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
increases response to substance |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
increases response to substance |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
affects response to substance |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
increases response to substance |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
affects binding |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
multiple interactions |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
multiple interactions |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
multiple interactions |
EXP |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
decreases expression |
EXP |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adora2b |
adenosine A2B receptor |
|
multiple interactions |
ISO |
10 |
48,421,592 |
48,437,967 |
RGD:6480464 |
CTD |
| G |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
multiple interactions |
ISO |
5 |
136,920,561 |
136,937,422 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases response to substance |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
|
decreases expression |
ISO |
1 |
245,685,979 |
245,718,198 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
multiple interactions |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
|
increases expression |
EXP |
13 |
83,017,312 |
83,034,047 |
RGD:6480464 |
CTD |
| G |
Ang |
angiogenin, ribonuclease, RNase A family, 5 |
|
decreases expression |
ISO |
15 |
27,083,089 |
27,083,526 |
RGD:6480464 |
CTD |
| G |
Ankrd37 |
ankyrin repeat domain 37 |
|
decreases expression |
EXP |
16 |
49,549,527 |
49,552,416 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
multiple interactions |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa2 |
apolipoprotein A-II |
|
multiple interactions |
ISO |
13 |
87,114,734 |
87,116,372 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apoc1 |
apolipoprotein C-I |
|
multiple interactions |
ISO |
1 |
78,996,677 |
78,999,960 |
RGD:6480464 |
CTD |
| G |
Apoc2 |
apolipoprotein C-II |
|
multiple interactions |
ISO |
1 |
78,979,034 |
78,984,002 |
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Arf1 |
ADP-ribosylation factor 1 |
|
multiple interactions |
ISO |
10 |
45,516,609 |
45,532,091 |
RGD:6480464 |
CTD |
| G |
Arl6ip1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
|
increases expression |
ISO |
1 |
176,332,729 |
176,342,244 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
increases expression |
EXP |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
decreases expression |
ISO |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Atg7 |
autophagy related 7 |
|
increases response to substance |
ISO |
4 |
150,814,706 |
150,992,704 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases activity |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases activity |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
affects response to substance |
ISO |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp5j2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 |
|
decreases expression |
ISO |
12 |
9,735,171 |
9,741,496 |
RGD:6480464 |
CTD |
| G |
Atp6v0c |
ATPase, H+ transporting, lysosomal V0 subunit C |
|
multiple interactions |
ISO |
10 |
13,415,671 |
13,420,715 |
RGD:6480464 |
CTD |
| G |
Atp6v1b2 |
ATPase, H transporting, lysosomal V1 subunit B2 |
|
multiple interactions |
ISO |
16 |
22,320,425 |
22,344,445 |
RGD:6480464 |
CTD |
| G |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
|
decreases expression |
EXP |
5 |
136,049,177 |
136,075,532 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
multiple interactions |
ISO |
8 |
100,936,342 |
101,014,881 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
multiple interactions |
ISO |
8 |
100,936,342 |
101,014,881 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
affects activity |
ISO |
8 |
100,936,342 |
101,014,881 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
multiple interactions |
ISO |
8 |
100,936,342 |
101,014,881 |
RGD:6480464 |
CTD |
| G |
Atrn |
attractin |
|
multiple interactions |
ISO |
3 |
118,539,268 |
118,701,177 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
multiple interactions |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
C1r |
complement component 1, r subcomponent |
|
multiple interactions |
ISO |
4 |
160,712,582 |
160,729,362 |
RGD:6480464 |
CTD |
| G |
C1s |
complement component 1, s subcomponent |
|
multiple interactions |
ISO |
4 |
160,736,133 |
160,748,133 |
RGD:6480464 |
CTD |
| G |
C2cd5 |
C2 calcium-dependent domain containing 5 |
|
increases expression |
EXP |
4 |
180,903,353 |
180,989,193 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
multiple interactions |
ISO |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Calu |
calumenin |
|
decreases expression |
ISO |
4 |
56,228,617 |
56,256,118 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
multiple interactions |
ISO |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
multiple interactions |
ISO |
4 |
70,029,728 |
70,047,164 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
affects cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbx5 |
chromobox homolog 5 |
|
multiple interactions |
ISO |
7 |
142,107,922 |
142,125,543 |
RGD:6480464 |
CTD |
| G |
Ccdc174 |
coiled-coil domain containing 174 |
|
decreases expression |
EXP |
4 |
126,074,136 |
126,100,614 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
multiple interactions |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Ccz1 |
CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae) |
|
decreases expression |
EXP |
12 |
10,929,886 |
10,953,939 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
increases expression |
EXP |
3 |
118,893,716 |
118,903,516 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
decreases expression |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
multiple interactions |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
multiple interactions |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
EXP |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
multiple interactions |
ISO |
19 |
2,225,209 |
2,382,805 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases activity |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cetn3 |
centrin, EF-hand protein, 3 |
|
multiple interactions |
ISO |
2 |
9,909,950 |
9,922,361 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
multiple interactions |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
multiple interactions |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
decreases phosphorylation |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
decreases expression |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
multiple interactions |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
multiple interactions |
ISO |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
decreases activity |
ISO |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
multiple interactions |
ISO |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
multiple interactions |
ISO |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
multiple interactions |
ISO |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
multiple interactions |
ISO |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Ckmt1b |
creatine kinase, mitochondrial 1B |
|
multiple interactions |
ISO |
3 |
108,158,887 |
108,163,888 |
RGD:6480464 |
CTD |
| G |
Clstn1 |
calsyntenin 1 |
|
multiple interactions |
ISO |
5 |
166,671,098 |
166,734,907 |
RGD:6480464 |
CTD |
| G |
Cobl |
cordon-bleu WH2 repeat protein |
|
affects expression |
EXP |
14 |
93,154,637 |
93,309,406 |
RGD:6480464 |
CTD |
| G |
Coch |
coagulation factor C homolog, cochlin (Limulus polyphemus) |
|
decreases expression |
EXP |
6 |
71,692,946 |
71,697,056 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Cox7a2l |
cytochrome c oxidase subunit VIIa polypeptide 2 like |
|
multiple interactions |
ISO |
6 |
6,834,523 |
6,861,652 |
RGD:6480464 |
CTD |
| G |
Cox7c |
cytochrome c oxidase, subunit VIIc |
|
multiple interactions |
ISO |
2 |
15,254,040 |
15,256,065 |
RGD:6480464 |
CTD |
| G |
Csnk2a2 |
casein kinase 2, alpha prime polypeptide |
|
decreases expression |
EXP |
19 |
10,015,369 |
10,054,662 |
RGD:6480464 |
CTD |
| G |
Cst3 |
cystatin C |
|
multiple interactions |
ISO |
3 |
137,650,903 |
137,654,776 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases mutagenesis |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
multiple interactions |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
multiple interactions |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
multiple interactions |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cyc1 |
cytochrome c-1 |
|
decreases expression |
ISO |
7 |
114,394,178 |
114,396,563 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects binding |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases methylation |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases methylation |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases activity |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases methylation |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
decreases activity |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases metabolic processing |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
decreases activity |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases activity |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
affects metabolic processing |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
affects metabolic processing |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
5 |
135,917,327 |
135,934,636 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
decreases expression |
EXP |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Dad1 |
defender against cell death 1 |
|
decreases expression |
ISO |
15 |
32,285,592 |
32,305,885 |
RGD:6480464 |
CTD |
| G |
Dcaf11 |
DDB1 and CUL4 associated factor 11 |
|
decreases expression |
EXP |
15 |
33,691,576 |
33,701,328 |
RGD:6480464 |
CTD |
| G |
Dct |
dopachrome tautomerase |
|
increases expression |
ISO |
15 |
102,798,699 |
102,832,240 |
RGD:6480464 |
CTD |
| G |
Dcxr |
dicarbonyl L-xylulose reductase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ddhd1 |
DDHD domain containing 1 |
|
increases expression |
EXP |
15 |
21,500,775 |
21,569,296 |
RGD:6480464 |
CTD |
| G |
Ddx31 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 |
|
decreases expression |
EXP |
3 |
7,849,554 |
7,914,005 |
RGD:6480464 |
CTD |
| G |
Dhcr24 |
24-dehydrocholesterol reductase |
|
decreases expression |
EXP |
5 |
127,637,438 |
127,662,621 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
multiple interactions |
ISO |
5 |
58,100,794 |
58,111,705 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
multiple interactions |
ISO |
6 |
63,583,033 |
63,587,247 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
multiple interactions |
ISO |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
affects response to substance |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
increases response to substance |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Dtx4 |
deltex homolog 4 (Drosophila) |
|
decreases expression |
EXP |
1 |
215,396,194 |
215,416,879 |
RGD:6480464 |
CTD |
| G |
Dusp8 |
dual specificity phosphatase 8 |
|
increases expression |
EXP |
1 |
202,215,086 |
202,229,746 |
RGD:6480464 |
CTD |
| G |
Ebpl |
emopamil binding protein-like |
|
decreases expression |
EXP |
15 |
40,484,464 |
40,506,451 |
RGD:6480464 |
CTD |
| G |
Eci1 |
enoyl-CoA delta isomerase 1 |
|
decreases expression |
EXP |
10 |
13,683,000 |
13,697,179 |
RGD:6480464 |
CTD |
| G |
Ecm1 |
extracellular matrix protein 1 |
|
multiple interactions |
ISO |
2 |
190,525,156 |
190,530,323 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases activity |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
multiple interactions |
ISO |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
multiple interactions |
ISO |
7 |
10,017,061 |
10,022,331 |
RGD:6480464 |
CTD |
| G |
Efna1 |
ephrin A1 |
|
multiple interactions |
ISO |
2 |
181,444,599 |
181,451,944 |
RGD:6480464 |
CTD |
| G |
Efnb3 |
ephrin B3 |
|
multiple interactions |
ISO |
10 |
56,373,322 |
56,379,316 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
decreases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Eif1 |
eukaryotic translation initiation factor 1 |
|
increases expression |
ISO |
10 |
89,255,637 |
89,257,728 |
RGD:6480464 |
CTD |
| G |
Eif1l1 |
eukaryotic translation initiation factor 1-like 1 |
|
increases expression |
ISO |
5 |
21,736,137 |
21,736,478 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
multiple interactions |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
decreases expression |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
decreases expression |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
multiple interactions |
ISO |
6 |
136,311,381 |
136,318,586 |
RGD:6480464 |
CTD |
| G |
Ell |
elongation factor RNA polymerase II |
|
decreases expression |
EXP |
16 |
19,349,939 |
19,397,253 |
RGD:6480464 |
CTD |
| G |
Emc6 |
ER membrane protein complex subunit 6 |
|
decreases expression |
EXP |
10 |
60,052,329 |
60,053,594 |
RGD:6480464 |
CTD |
| G |
Endod1 |
endonuclease domain containing 1 |
|
decreases expression |
EXP |
8 |
11,151,051 |
11,180,463 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
multiple interactions |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
multiple interactions |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
multiple interactions |
ISO |
10 |
95,794,488 |
95,855,895 |
RGD:6480464 |
CTD |
| G |
Erp44 |
endoplasmic reticulum protein 44 |
|
multiple interactions |
ISO |
5 |
64,869,536 |
64,962,569 |
RGD:6480464 |
CTD |
| G |
Esyt2 |
extended synaptotagmin-like protein 2 |
|
decreases expression |
EXP |
6 |
143,566,626 |
143,657,881 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
multiple interactions |
ISO |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
Fastkd3 |
FAST kinase domains 3 |
|
decreases expression |
EXP |
17 |
5,077,472 |
5,086,004 |
RGD:6480464 |
CTD |
| G |
Fbln2 |
fibulin 2 |
|
increases expression |
EXP |
4 |
125,380,549 |
125,441,079 |
RGD:6480464 |
CTD |
| G |
Fbrs |
fibrosin |
|
increases expression |
EXP |
1 |
186,765,024 |
186,777,299 |
RGD:6480464 |
CTD |
| G |
Fbxl12 |
F-box and leucine-rich repeat protein 12 |
|
multiple interactions |
ISO |
8 |
19,656,937 |
19,661,560 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
decreases expression |
EXP |
15 |
42,425,336 |
42,453,390 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
decreases expression |
EXP |
8 |
55,291,396 |
55,310,507 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
increases expression |
EXP |
X |
141,315,765 |
141,329,278 |
RGD:6480464 |
CTD |
| G |
Filip1l |
filamin A interacting protein 1-like |
|
increases expression |
EXP |
11 |
43,788,676 |
43,859,932 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fuk |
fucokinase |
|
increases expression |
EXP |
19 |
40,803,644 |
40,823,587 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
multiple interactions |
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Gale |
UDP-galactose-4-epimerase |
|
multiple interactions |
ISO |
5 |
154,745,853 |
154,750,357 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
multiple interactions |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gast |
gastrin |
|
increases secretion |
EXP |
10 |
89,273,628 |
89,276,192 |
RGD:6480464 |
CTD |
| G |
Gdf10 |
growth differentiation factor 10 |
|
decreases expression |
EXP |
16 |
9,558,781 |
9,570,656 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Ghitm |
growth hormone inducible transmembrane protein |
|
multiple interactions |
ISO |
16 |
13,327,337 |
13,338,420 |
RGD:6480464 |
CTD |
| G |
Glrx |
glutaredoxin (thioltransferase) |
|
decreases expression |
ISO |
2 |
2,888,605 |
2,899,216 |
RGD:6480464 |
CTD |
| G |
Glt8d1 |
glycosyltransferase 8 domain containing 1 |
|
decreases expression |
ISO |
16 |
6,429,357 |
6,444,262 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
decreases expression |
ISO |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Gmfb |
glia maturation factor, beta |
|
multiple interactions |
ISO |
15 |
22,664,728 |
22,675,100 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
decreases expression |
EXP |
4 |
12,465,089 |
12,495,028 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
increases expression |
EXP |
4 |
12,465,089 |
12,495,028 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
decreases expression |
EXP |
8 |
112,861,952 |
112,882,647 |
RGD:6480464 |
CTD |
| G |
Gnal |
guanine nucleotide binding protein, alpha stimulating, olfactory type |
|
increases response to substance |
ISO |
18 |
63,595,606 |
63,735,803 |
RGD:6480464 |
CTD |
| G |
Gnaq |
guanine nucleotide binding protein (G protein), q polypeptide |
|
decreases expression |
EXP |
1 |
219,520,998 |
219,764,401 |
RGD:6480464 |
CTD |
| G |
Gnas |
GNAS complex locus |
|
decreases expression |
EXP |
3 |
165,213,399 |
165,214,551 |
RGD:6480464 |
CTD |
| G |
Golt1b |
golgi transport 1B |
|
multiple interactions |
ISO |
4 |
179,952,033 |
179,963,246 |
RGD:6480464 |
CTD |
| G |
Gosr1 |
golgi SNAP receptor complex member 1 |
|
decreases expression |
EXP |
10 |
67,407,203 |
67,442,601 |
RGD:6480464 |
CTD |
| G |
Gpc3 |
glypican 3 |
|
affects expression |
EXP |
X |
139,192,115 |
139,560,649 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
multiple interactions |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
|
multiple interactions |
ISO |
4 |
92,642,427 |
94,054,757 |
RGD:6480464 |
CTD |
| G |
Grm1 |
glutamate receptor, metabotropic 1 |
|
decreases expression |
EXP |
1 |
5,318,617 |
5,744,593 |
RGD:6480464 |
CTD |
| G |
Grpr |
gastrin releasing peptide receptor |
|
decreases expression |
EXP |
X |
51,743,248 |
51,783,255 |
RGD:6480464 |
CTD |
| G |
Grwd1 |
glutamate-rich WD repeat containing 1 |
|
decreases expression |
EXP |
1 |
96,301,559 |
96,307,145 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gstm6 |
glutathione S-transferase, mu 6 |
|
multiple interactions |
ISO |
2 |
203,504,228 |
203,509,002 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
decreases expression |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
multiple interactions |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
multiple interactions |
EXP |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
multiple interactions |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
multiple interactions |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Hba2 |
hemoglobin, alpha 2 |
|
multiple interactions |
ISO |
10 |
15,570,930 |
15,571,773 |
RGD:6480464 |
CTD |
| G |
Heca |
headcase homolog (Drosophila) |
|
increases expression |
EXP |
1 |
12,933,861 |
12,947,642 |
RGD:6480464 |
CTD |
| G |
Hells |
helicase, lymphoid specific |
|
multiple interactions |
ISO |
1 |
243,246,843 |
243,262,459 |
RGD:6480464 |
CTD |
| G |
Hells |
helicase, lymphoid specific |
|
increases expression |
ISO |
1 |
243,246,843 |
243,262,459 |
RGD:6480464 |
CTD |
| G |
Hint1 |
histidine triad nucleotide binding protein 1 |
|
multiple interactions |
ISO |
10 |
40,271,895 |
40,275,640 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
decreases expression |
EXP |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Homer1 |
homer homolog 1 (Drosophila) |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
multiple interactions |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hrmt1l3 |
HMT1 hnRNP methyltransferase-like 3 (S. cerevisiae) |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
increases expression |
EXP |
13 |
109,063,491 |
109,089,468 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
decreases expression |
EXP |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
decreases expression |
ISO |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
multiple interactions |
ISO |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
|
decreases expression |
EXP |
13 |
85,776,077 |
85,792,977 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
multiple interactions |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb6 |
heat shock protein, alpha-crystallin-related, B6 |
|
increases expression |
EXP |
1 |
85,599,075 |
85,601,214 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
multiple interactions |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
multiple interactions |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
increases expression |
EXP |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
|
decreases expression |
EXP |
17 |
72,557,196 |
72,563,149 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases secretion |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
decreases expression |
EXP |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
increases expression |
EXP |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Il10rb |
interleukin 10 receptor, beta |
|
increases expression |
EXP |
11 |
31,381,317 |
31,397,079 |
RGD:6480464 |
CTD |
| G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
increases expression |
ISO |
9 |
39,577,879 |
39,624,781 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
increases expression |
EXP |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
multiple interactions |
ISO |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Ino80c |
INO80 complex subunit C |
|
decreases expression |
EXP |
18 |
15,863,573 |
15,878,207 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases secretion |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
decreases expression |
EXP |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
decreases expression |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
multiple interactions |
ISO |
X |
159,960,184 |
159,969,180 |
RGD:6480464 |
CTD |
| G |
Irx3 |
iroquois homeobox 3 |
|
multiple interactions |
ISO |
19 |
16,345,179 |
16,347,455 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itm2b |
integral membrane protein 2B |
|
multiple interactions |
ISO |
15 |
54,005,134 |
54,028,036 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
decreases expression |
ISO |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases phosphorylation |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kctd14 |
potassium channel tetramerisation domain containing 14 |
|
decreases expression |
EXP |
1 |
154,686,321 |
154,691,235 |
RGD:6480464 |
CTD |
| G |
Kidins220 |
kinase D-interacting substrate 220 |
|
increases expression |
EXP |
6 |
42,649,878 |
42,740,157 |
RGD:6480464 |
CTD |
| G |
Kif3b |
kinesin family member 3B |
|
multiple interactions |
ISO |
3 |
143,642,175 |
143,681,902 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
decreases expression |
ISO |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
increases expression |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Leprel2 |
leprecan-like 2 |
|
multiple interactions |
ISO |
4 |
160,964,297 |
160,978,321 |
RGD:6480464 |
CTD |
| G |
Lpar4 |
lysophosphatidic acid receptor 4 |
|
multiple interactions |
ISO |
X |
95,180,476 |
95,194,380 |
RGD:6480464 |
CTD |
| G |
Lphn1 |
latrophilin 1 |
|
multiple interactions |
ISO |
19 |
25,891,157 |
25,931,128 |
RGD:6480464 |
CTD |
| G |
Lysmd2 |
LysM, putative peptidoglycan-binding, domain containing 2 |
|
decreases expression |
EXP |
8 |
80,446,544 |
80,462,607 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
multiple interactions |
ISO |
X |
17,678,960 |
17,745,908 |
RGD:6480464 |
CTD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
multiple interactions |
ISO |
12 |
1,545,407 |
1,552,353 |
RGD:6480464 |
CTD |
| G |
Map3k12 |
mitogen activated protein kinase kinase kinase 12 |
|
multiple interactions |
ISO |
7 |
141,254,451 |
141,264,979 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk15 |
mitogen-activated protein kinase 15 |
|
increases expression |
EXP |
7 |
114,026,694 |
114,032,007 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases expression |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
March11 |
membrane-associated ring finger (C3HC4) 11 |
|
decreases expression |
EXP |
2 |
77,989,651 |
78,090,956 |
RGD:6480464 |
CTD |
| G |
Mc2r |
melanocortin 2 receptor (adrenocorticotropic hormone) |
|
multiple interactions |
ISO |
18 |
64,591,344 |
64,601,883 |
RGD:6480464 |
CTD |
| G |
Mcm3 |
minichromosome maintenance complex component 3 |
|
increases expression |
ISO |
9 |
19,536,922 |
19,554,871 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
decreases expression |
ISO |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Micb |
MHC class I polypeptide-related sequence B |
|
multiple interactions |
ISO |
1 |
78,199,668 |
78,216,687 |
RGD:6480464 |
CTD |
| G |
Micb |
MHC class I polypeptide-related sequence B |
|
multiple interactions |
ISO |
1 |
78,199,668 |
78,216,687 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
multiple interactions |
ISO |
8 |
4,526,018 |
4,533,730 |
RGD:6480464 |
CTD |
| G |
Mogat1 |
monoacylglycerol O-acyltransferase 1 |
|
decreases expression |
EXP |
9 |
77,901,139 |
77,908,689 |
RGD:6480464 |
CTD |
| G |
Mrpl19 |
mitochondrial ribosomal protein L19 |
|
decreases expression |
EXP |
4 |
116,207,542 |
116,211,771 |
RGD:6480464 |
CTD |
| G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
|
multiple interactions |
ISO |
5 |
172,657,923 |
172,662,453 |
RGD:6480464 |
CTD |
| G |
mrpl9 |
mitochondrial ribosomal protein L9 |
|
multiple interactions |
ISO |
2 |
189,417,391 |
189,422,111 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
decreases expression |
EXP |
6 |
11,199,906 |
11,258,350 |
RGD:6480464 |
CTD |
| G |
Msmo1 |
methylsterol monooxygenase 1 |
|
decreases expression |
EXP |
16 |
26,698,324 |
26,716,247 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mtch1 |
mitochondrial carrier 1 |
|
multiple interactions |
ISO |
20 |
7,649,782 |
7,673,289 |
RGD:6480464 |
CTD |
| G |
Mtf2 |
metal response element binding transcription factor 2 |
|
multiple interactions |
ISO |
14 |
2,189,596 |
2,232,660 |
RGD:6480464 |
CTD |
| G |
Mthfd2l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like |
|
decreases expression |
EXP |
14 |
18,585,147 |
18,665,534 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases activity |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
|
decreases expression |
EXP |
17 |
5,086,219 |
5,118,086 |
RGD:6480464 |
CTD |
| G |
Mutyh |
mutY homolog (E. coli) |
|
increases expression |
EXP |
5 |
137,103,958 |
137,115,897 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases acetylation |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Ndufb5 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 |
|
multiple interactions |
ISO |
2 |
118,946,438 |
118,963,186 |
RGD:6480464 |
CTD |
| G |
Ndufs4 |
NADH dehydrogenase (ubiquinone) Fe-S protein 4 |
|
multiple interactions |
ISO |
2 |
45,839,236 |
46,479,619 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Npl |
N-acetylneuraminate pyruvate lyase |
|
multiple interactions |
ISO |
13 |
68,524,023 |
68,567,312 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
increases expression |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
|
increases expression |
EXP |
19 |
32,527,752 |
32,875,369 |
RGD:6480464 |
CTD |
| G |
Nrf1 |
nuclear respiratory factor 1 |
|
decreases expression |
EXP |
4 |
56,949,553 |
57,048,149 |
RGD:6480464 |
CTD |
| G |
Nsf |
N-ethylmaleimide-sensitive factor |
|
multiple interactions |
ISO |
10 |
92,974,385 |
93,082,222 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
multiple interactions |
ISO |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
increases expression |
ISO |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
increases expression |
ISO |
5 |
80,325,042 |
80,328,194 |
RGD:6480464 |
CTD |
| G |
Oxsr1 |
oxidative-stress responsive 1 |
|
increases expression |
EXP |
8 |
124,196,599 |
124,286,647 |
RGD:6480464 |
CTD |
| G |
Pak2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
|
increases activity |
ISO |
11 |
70,529,961 |
70,588,511 |
RGD:6480464 |
CTD |
| G |
Pak2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
|
multiple interactions |
ISO |
11 |
70,529,961 |
70,588,511 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
affects cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pde11a |
phosphodiesterase 11A |
|
decreases expression |
EXP |
3 |
58,659,595 |
59,049,869 |
RGD:6480464 |
CTD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
decreases expression |
EXP |
2 |
219,410,394 |
219,550,910 |
RGD:6480464 |
CTD |
| G |
Pdhx |
pyruvate dehydrogenase complex, component X |
|
decreases expression |
EXP |
3 |
88,240,250 |
88,270,914 |
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pfdn1 |
prefoldin subunit 1 |
|
multiple interactions |
ISO |
18 |
29,043,386 |
29,096,475 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Phex |
phosphate regulating endopeptidase homolog, X-linked |
|
increases expression |
ISO |
X |
58,911,144 |
59,168,857 |
RGD:6480464 |
CTD |
| G |
Phtf1 |
putative homeodomain transcription factor 1 |
|
multiple interactions |
ISO |
2 |
199,202,647 |
199,241,476 |
RGD:6480464 |
CTD |
| G |
Pidd |
p53-induced death domain protein |
|
multiple interactions |
ISO |
1 |
201,626,042 |
201,631,182 |
RGD:6480464 |
CTD |
| G |
Pigc |
phosphatidylinositol glycan anchor biosynthesis, class C |
|
multiple interactions |
ISO |
13 |
77,664,442 |
77,666,797 |
RGD:6480464 |
CTD |
| G |
Pip5k1c |
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma |
|
multiple interactions |
ISO |
7 |
9,881,767 |
9,909,651 |
RGD:6480464 |
CTD |
| G |
Pitx2 |
paired-like homeodomain 2 |
|
decreases expression |
EXP |
2 |
226,581,170 |
226,601,319 |
RGD:6480464 |
CTD |
| G |
Pkd1 |
polycystic kidney disease 1 homolog (human) |
|
multiple interactions |
ISO |
10 |
13,801,445 |
13,848,212 |
RGD:6480464 |
CTD |
| G |
Pkd1 |
polycystic kidney disease 1 homolog (human) |
|
affects response to substance |
ISO |
10 |
13,801,445 |
13,848,212 |
RGD:6480464 |
CTD |
| G |
Plcb1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
|
multiple interactions |
EXP |
3 |
122,797,718 |
123,523,675 |
RGD:6480464 |
CTD |
| G |
Plcb1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
|
decreases expression |
EXP |
3 |
122,797,718 |
123,523,675 |
RGD:6480464 |
CTD |
| G |
Plp1 |
proteolipid protein 1 |
|
increases expression |
ISO |
X |
124,488,627 |
124,503,639 |
RGD:6480464 |
CTD |
| G |
Pnpla8 |
patatin-like phospholipase domain containing 8 |
|
multiple interactions |
ISO |
6 |
63,644,462 |
63,676,544 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
increases secretion |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Ppm1b |
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
|
multiple interactions |
ISO |
6 |
8,319,544 |
8,373,795 |
RGD:6480464 |
CTD |
| G |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
|
decreases expression |
ISO |
18 |
35,865,837 |
36,318,308 |
RGD:6480464 |
CTD |
| G |
Ppp2r3c |
protein phosphatase 2, regulatory subunit B'', gamma |
|
multiple interactions |
ISO |
6 |
75,516,505 |
75,539,654 |
RGD:6480464 |
CTD |
| G |
Prelid1 |
PRELI domain containing 1 |
|
decreases expression |
ISO |
17 |
15,350,084 |
15,353,124 |
RGD:6480464 |
CTD |
| G |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
|
increases expression |
EXP |
5 |
126,007,672 |
126,074,012 |
RGD:6480464 |
CTD |
| G |
Prkdc |
protein kinase, DNA activated, catalytic polypeptide |
|
multiple interactions |
ISO |
11 |
86,951,420 |
87,169,229 |
RGD:6480464 |
CTD |
| G |
Prkdc |
protein kinase, DNA activated, catalytic polypeptide |
|
multiple interactions |
ISO |
11 |
86,951,420 |
87,169,229 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
decreases expression |
ISO |
3 |
119,676,137 |
119,691,507 |
RGD:6480464 |
CTD |
| G |
Prorsd1 |
prolyl-tRNA synthetase associated domain containing 1 |
|
decreases expression |
EXP |
14 |
110,530,889 |
110,533,157 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
multiple interactions |
ISO |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Psme3 |
proteasome (prosome, macropain) activator subunit 3 |
|
decreases expression |
ISO |
10 |
90,343,493 |
90,351,335 |
RGD:6480464 |
CTD |
| G |
Ptgfrn |
prostaglandin F2 receptor inhibitor |
|
increases expression |
EXP |
2 |
196,091,505 |
196,162,950 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptpla |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member a |
|
decreases expression |
EXP |
17 |
88,239,568 |
88,253,571 |
RGD:6480464 |
CTD |
| G |
Pwp2 |
PWP2 periodic tryptophan protein homolog (yeast) |
|
decreases expression |
EXP |
20 |
10,836,094 |
10,849,727 |
RGD:6480464 |
CTD |
| G |
Qrsl1 |
glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 |
|
decreases expression |
EXP |
20 |
47,793,416 |
47,818,351 |
RGD:6480464 |
CTD |
| G |
Rab3ip |
RAB3A interacting protein |
|
increases expression |
EXP |
7 |
56,229,363 |
56,258,007 |
RGD:6480464 |
CTD |
| G |
Rab7a |
RAB7A, member RAS oncogene family |
|
multiple interactions |
ISO |
4 |
122,202,685 |
122,220,649 |
RGD:6480464 |
CTD |
| G |
Rabgef1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
|
decreases expression |
EXP |
12 |
27,497,545 |
27,525,385 |
RGD:6480464 |
CTD |
| G |
Rabl3 |
RAB, member of RAS oncogene family-like 3 |
|
decreases expression |
EXP |
11 |
64,943,199 |
64,972,157 |
RGD:6480464 |
CTD |
| G |
Rad1 |
RAD1 homolog (S. pombe) |
|
multiple interactions |
ISO |
2 |
59,837,934 |
59,845,973 |
RGD:6480464 |
CTD |
| G |
Rad50 |
RAD50 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
10 |
39,112,733 |
39,164,694 |
RGD:6480464 |
CTD |
| G |
Rad51ap1 |
RAD51 associated protein 1 |
|
increases expression |
ISO |
4 |
163,308,788 |
163,321,854 |
RGD:6480464 |
CTD |
| G |
Rasa3 |
RAS p21 protein activator 3 |
|
multiple interactions |
ISO |
16 |
80,710,463 |
80,824,220 |
RGD:6480464 |
CTD |
| G |
Rasa3 |
RAS p21 protein activator 3 |
|
multiple interactions |
ISO |
16 |
80,710,463 |
80,824,220 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases phosphorylation |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases phosphorylation |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbbp4 |
retinoblastoma binding protein 4 |
|
multiple interactions |
ISO |
5 |
148,472,397 |
148,492,172 |
RGD:6480464 |
CTD |
| G |
Rbbp5 |
retinoblastoma binding protein 5 |
|
multiple interactions |
ISO |
13 |
45,364,906 |
45,391,757 |
RGD:6480464 |
CTD |
| G |
Rbm12 |
RNA binding motif protein 12 |
|
decreases expression |
EXP |
3 |
146,504,101 |
146,521,424 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases activity |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases expression |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases activity |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases secretion |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
RGD1309077 |
similar to putative RNA methyltransferase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1562301 |
similar to glutaminyl-tRNA synthetase |
|
increases expression |
EXP |
8 |
113,556,500 |
113,563,232 |
RGD:6480464 |
CTD |
| G |
RGD1563084 |
similar to FLJ20298 protein isoform a |
|
increases expression |
EXP |
X |
127,388,586 |
127,484,707 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
multiple interactions |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rhebl1 |
Ras homolog enriched in brain like 1 |
|
increases expression |
EXP |
7 |
137,645,541 |
137,649,476 |
RGD:6480464 |
CTD |
| G |
Rims2 |
regulating synaptic membrane exocytosis 2 |
|
decreases expression |
EXP |
7 |
74,757,003 |
75,271,771 |
RGD:6480464 |
CTD |
| G |
Rnf166 |
ring finger protein 166 |
|
increases expression |
EXP |
19 |
52,755,818 |
52,765,658 |
RGD:6480464 |
CTD |
| G |
Rpia |
ribose 5-phosphate isomerase A |
|
decreases expression |
EXP |
4 |
103,934,938 |
103,960,574 |
RGD:6480464 |
CTD |
| G |
Rpl26 |
ribosomal protein L26 |
|
multiple interactions |
ISO |
10 |
55,662,220 |
55,665,752 |
RGD:6480464 |
CTD |
| G |
Rpl5l1 |
ribosomal protein L5-like 1 |
|
multiple interactions |
ISO |
9 |
113,233,164 |
113,234,057 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
decreases expression |
EXP |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
decreases expression |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6ka3 |
ribosomal protein S6 kinase polypeptide 3 |
|
decreases expression |
ISO |
X |
56,722,878 |
56,825,444 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
decreases expression |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
decreases expression |
EXP |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rrs1 |
RRS1 ribosome biogenesis regulator homolog (S. cerevisiae) |
|
increases expression |
ISO |
5 |
9,304,448 |
9,306,081 |
RGD:6480464 |
CTD |
| G |
Rspo3 |
R-spondin 3 |
|
multiple interactions |
ISO |
1 |
29,072,171 |
29,156,096 |
RGD:6480464 |
CTD |
| G |
Rwdd2b |
RWD domain containing 2B |
|
decreases expression |
EXP |
11 |
27,189,244 |
27,197,900 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
increases activity |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
increases activity |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
increases response to substance |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
increases response to substance |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
multiple interactions |
EXP |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
decreases expression |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scfd1 |
sec1 family domain containing 1 |
|
decreases expression |
ISO |
6 |
71,453,366 |
71,532,347 |
RGD:6480464 |
CTD |
| G |
Sec13 |
SEC13 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
149,637,058 |
149,650,449 |
RGD:6480464 |
CTD |
| G |
Sec23a |
Sec23 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
6 |
79,660,575 |
79,706,898 |
RGD:6480464 |
CTD |
| G |
Senp6 |
SUMO1/sentrin specific peptidase 6 |
|
multiple interactions |
ISO |
8 |
85,123,804 |
85,183,953 |
RGD:6480464 |
CTD |
| G |
Sept7 |
septin 7 |
|
multiple interactions |
ISO |
8 |
24,924,747 |
24,988,221 |
RGD:6480464 |
CTD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
increases expression |
ISO |
6 |
127,998,617 |
128,021,719 |
RGD:6480464 |
CTD |
| G |
Serpina6 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
|
decreases expression |
ISO |
6 |
127,911,618 |
127,921,851 |
RGD:6480464 |
CTD |
| G |
Sfpq |
splicing factor proline/glutamine-rich |
|
multiple interactions |
ISO |
5 |
146,460,306 |
146,469,289 |
RGD:6480464 |
CTD |
| G |
Sharpin |
SHANK-associated RH domain interactor |
|
increases expression |
EXP |
7 |
114,397,762 |
114,401,974 |
RGD:6480464 |
CTD |
| G |
Sigmar1 |
sigma non-opioid intracellular receptor 1 |
|
decreases expression |
EXP |
5 |
59,162,537 |
59,165,315 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
multiple interactions |
ISO |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
increases expression |
ISO |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc17a5 |
solute carrier family 17 (anion/sugar transporter), member 5 |
|
increases expression |
EXP |
8 |
83,516,448 |
83,551,409 |
RGD:6480464 |
CTD |
| G |
Slc24a6 |
solute carrier family 24 (sodium/lithium/calcium exchanger), member 6 |
|
increases expression |
EXP |
12 |
37,227,844 |
37,250,698 |
RGD:6480464 |
CTD |
| G |
Slc25a37 |
solute carrier family 25 (mitochondrial iron transporter), member 37 |
|
decreases expression |
EXP |
15 |
49,806,324 |
49,846,988 |
RGD:6480464 |
CTD |
| G |
Slc30a7 |
solute carrier family 30 (zinc transporter), member 7 |
|
decreases expression |
EXP |
2 |
212,088,266 |
212,162,896 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases response to substance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Smad1 |
SMAD family member 1 |
|
multiple interactions |
ISO |
19 |
30,348,886 |
30,409,345 |
RGD:6480464 |
CTD |
| G |
Smad3 |
SMAD family member 3 |
|
multiple interactions |
ISO |
8 |
67,803,909 |
67,952,056 |
RGD:6480464 |
CTD |
| G |
Smox |
spermine oxidase |
|
increases expression |
ISO |
3 |
119,240,376 |
119,254,370 |
RGD:6480464 |
CTD |
| G |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral membrane |
|
multiple interactions |
ISO |
19 |
36,112,166 |
36,195,564 |
RGD:6480464 |
CTD |
| G |
Snx3 |
sorting nexin 3 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
decreases expression |
EXP |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
decreases expression |
ISO |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
increases expression |
EXP |
10 |
35,751,300 |
35,762,630 |
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
decreases expression |
ISO |
10 |
35,751,300 |
35,762,630 |
RGD:6480464 |
CTD |
| G |
Srp9 |
signal recognition particle 9 |
|
multiple interactions |
ISO |
13 |
98,125,510 |
98,133,650 |
RGD:6480464 |
CTD |
| G |
Srsf1 |
serine/arginine-rich splicing factor 1 |
|
decreases expression |
ISO |
10 |
76,339,824 |
76,344,552 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases methylation |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Stard4 |
StAR-related lipid transfer (START) domain containing 4 |
|
decreases expression |
EXP |
18 |
25,638,433 |
25,653,958 |
RGD:6480464 |
CTD |
| G |
Stim1 |
stromal interaction molecule 1 |
|
increases expression |
EXP |
1 |
159,761,567 |
159,925,836 |
RGD:6480464 |
CTD |
| G |
Stip1 |
stress-induced phosphoprotein 1 |
|
multiple interactions |
ISO |
1 |
209,693,427 |
209,712,779 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
ISO |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Strbp |
spermatid perinuclear RNA binding protein |
|
decreases expression |
ISO |
3 |
17,338,337 |
17,411,975 |
RGD:6480464 |
CTD |
| G |
Stx4 |
syntaxin 4 |
|
multiple interactions |
ISO |
1 |
187,125,847 |
187,132,932 |
RGD:6480464 |
CTD |
| G |
Syt4 |
synaptotagmin IV |
|
multiple interactions |
ISO |
18 |
23,805,080 |
23,814,489 |
RGD:6480464 |
CTD |
| G |
Taf1d |
TATA box binding protein (Tbp)-associated factor, RNA polymerase I, D |
|
decreases expression |
EXP |
8 |
12,107,144 |
12,117,177 |
RGD:6480464 |
CTD |
| G |
Tbrg4 |
transforming growth factor beta regulator 4 |
|
decreases expression |
EXP |
14 |
87,372,275 |
87,378,266 |
RGD:6480464 |
CTD |
| G |
Tdo2 |
tryptophan 2,3-dioxygenase |
|
increases activity |
EXP |
2 |
173,594,020 |
173,611,833 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
multiple interactions |
ISO |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tirap |
toll-interleukin 1 receptor (TIR) domain-containing adaptor protein |
|
multiple interactions |
ISO |
8 |
34,966,856 |
34,969,727 |
RGD:6480464 |
CTD |
| G |
Tlcd1 |
TLC domain containing 1 |
|
decreases expression |
EXP |
10 |
64,454,775 |
64,456,808 |
RGD:6480464 |
CTD |
| G |
Tm9sf1 |
transmembrane 9 superfamily member 1 |
|
decreases expression |
ISO |
15 |
33,771,498 |
33,778,965 |
RGD:6480464 |
CTD |
| G |
Tmcc2 |
transmembrane and coiled-coil domain family 2 |
|
increases expression |
ISO |
13 |
45,246,328 |
45,283,883 |
RGD:6480464 |
CTD |
| G |
Tmed5 |
transmembrane emp24 protein transport domain containing 5 |
|
decreases expression |
EXP |
14 |
2,155,594 |
2,167,280 |
RGD:6480464 |
CTD |
| G |
Tmem69 |
transmembrane protein 69 |
|
decreases expression |
EXP |
5 |
136,831,040 |
136,834,619 |
RGD:6480464 |
CTD |
| G |
Tmem97 |
transmembrane protein 97 |
|
decreases expression |
ISO |
10 |
64,652,641 |
64,661,724 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
|
increases expression |
EXP |
15 |
40,051,695 |
40,117,968 |
RGD:6480464 |
CTD |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
increases expression |
ISO |
13 |
77,026,337 |
77,050,223 |
RGD:6480464 |
CTD |
| G |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
|
multiple interactions |
ISO |
11 |
69,927,509 |
69,966,854 |
RGD:6480464 |
CTD |
| G |
Tnks2 |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 |
|
increases expression |
EXP |
1 |
241,112,141 |
241,164,804 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases mutagenesis |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tph2 |
tryptophan hydroxylase 2 |
|
multiple interactions |
ISO |
7 |
54,321,033 |
54,430,706 |
RGD:6480464 |
CTD |
| G |
Tpp2 |
tripeptidyl peptidase II |
|
multiple interactions |
ISO |
9 |
42,984,834 |
43,066,195 |
RGD:6480464 |
CTD |
| G |
Tpra1 |
transmembrane protein, adipocyte asscociated 1 |
|
increases expression |
EXP |
4 |
123,001,474 |
123,006,178 |
RGD:6480464 |
CTD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
multiple interactions |
ISO |
2 |
123,117,180 |
123,184,016 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
decreases expression |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
decreases expression |
EXP |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyw5 |
tRNA-yW synthesizing protein 5 |
|
decreases expression |
EXP |
9 |
56,283,826 |
56,302,571 |
RGD:6480464 |
CTD |
| G |
Ubb |
ubiquitin B |
|
multiple interactions |
ISO |
10 |
139,578,694 |
139,579,068 |
RGD:6480464 |
CTD |
| G |
Ubc |
ubiquitin C |
|
multiple interactions |
ISO |
12 |
32,333,211 |
32,337,944 |
RGD:6480464 |
CTD |
| G |
Ube2d2 |
ubiquitin-conjugating enzyme E2D 2 |
|
multiple interactions |
ISO |
18 |
28,426,503 |
28,434,785 |
RGD:6480464 |
CTD |
| G |
Ubiad1 |
UbiA prenyltransferase domain containing 1 |
|
decreases expression |
EXP |
5 |
165,515,219 |
165,526,817 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
multiple interactions |
ISO |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Uqcrc2 |
ubiquinol cytochrome c reductase core protein 2 |
|
decreases expression |
ISO |
1 |
179,459,817 |
179,490,381 |
RGD:6480464 |
CTD |
| G |
Uros |
uroporphyrinogen III synthase |
|
multiple interactions |
ISO |
1 |
193,184,946 |
193,205,475 |
RGD:6480464 |
CTD |
| G |
Usp11 |
ubiquitin specific peptidase 11 |
|
increases expression |
EXP |
X |
12,890,515 |
12,906,686 |
RGD:6480464 |
CTD |
| G |
Utp18 |
UTP18, small subunit (SSU) processome component, homolog (yeast) |
|
decreases expression |
EXP |
10 |
82,515,696 |
82,542,665 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vps41 |
vacuolar protein sorting 41 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
17 |
53,893,474 |
54,063,005 |
RGD:6480464 |
CTD |
| G |
Wbp4 |
WW domain binding protein 4 |
|
multiple interactions |
ISO |
15 |
61,517,401 |
61,543,453 |
RGD:6480464 |
CTD |
| G |
Wdr43 |
WD repeat domain 43 |
|
decreases expression |
EXP |
6 |
23,950,923 |
23,990,272 |
RGD:6480464 |
CTD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
affects expression |
EXP |
5 |
156,064,371 |
156,083,198 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
affects metabolic processing |
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
affects metabolic processing |
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
affects metabolic processing |
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
affects metabolic processing |
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
affects metabolic processing |
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
affects metabolic processing |
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
affects metabolic processing |
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xkr5 |
XK, Kell blood group complex subunit-related family, member 5 |
|
decreases expression |
EXP |
16 |
75,677,746 |
75,695,654 |
RGD:6480464 |
CTD |
| G |
Ywhaq |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
|
multiple interactions |
ISO |
6 |
41,945,769 |
41,976,123 |
RGD:6480464 |
CTD |
| G |
Zfp276 |
zinc finger protein (C2H2 type) 276 |
|
decreases expression |
EXP |
19 |
53,575,020 |
53,588,068 |
RGD:6480464 |
CTD |
| G |
Zfp553 |
zinc finger protein 553 |
|
decreases expression |
EXP |
1 |
186,497,357 |
186,501,551 |
RGD:6480464 |
CTD |
| G |
Zfp819 |
zinc finger protein 819 |
|
decreases expression |
EXP |
1 |
94,009,048 |
94,019,562 |
RGD:6480464 |
CTD |
rolipram
|
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
increases expression |
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
decreases activity |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
increases activity |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases expression |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases activity |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
decreases expression |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
decreases secretion |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ltc4s |
leukotriene C4 synthase |
|
decreases secretion |
ISO |
10 |
35,786,877 |
35,788,838 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
increases expression |
EXP |
17 |
11,494,463 |
11,811,654 |
RGD:6480464 |
CTD |
| G |
Pde4a |
phosphodiesterase 4A, cAMP-specific |
|
multiple interactions |
ISO |
8 |
20,192,677 |
20,241,557 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
multiple interactions |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
multiple interactions |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Sele |
selectin E |
|
multiple interactions |
ISO |
13 |
79,813,455 |
79,822,845 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
theophylline
|
| G |
Abhd11 |
abhydrolase domain containing 11 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abl2 |
v-abl Abelson murine leukemia viral oncogene homolog 2 |
|
decreases expression |
ISO |
13 |
71,546,918 |
71,915,301 |
RGD:6480464 |
CTD |
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
increases activity |
EXP |
4 |
76,957,477 |
76,977,643 |
RGD:6480464 |
CTD |
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
decreases expression |
ISO |
4 |
76,957,477 |
76,977,643 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
multiple interactions |
ISO |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
decreases expression |
EXP |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acot7 |
acyl-CoA thioesterase 7 |
|
multiple interactions |
ISO |
5 |
169,409,306 |
169,501,907 |
RGD:6480464 |
CTD |
| G |
Actr2 |
ARP2 actin-related protein 2 homolog (yeast) |
|
decreases expression |
ISO |
14 |
100,848,391 |
100,883,833 |
RGD:6480464 |
CTD |
| G |
Adad1 |
adenosine deaminase domain containing 1 (testis specific) |
|
decreases expression |
ISO |
2 |
123,599,135 |
123,632,850 |
RGD:6480464 |
CTD |
| G |
Adamtsl3 |
ADAMTS-like 3 |
|
multiple interactions |
ISO |
1 |
138,563,870 |
138,876,886 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
decreases activity |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adrbk2 |
adrenergic, beta, receptor kinase 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adrbk2 |
adrenergic, beta, receptor kinase 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Aff4 |
AF4/FMR2 family, member 4 |
|
multiple interactions |
ISO |
10 |
38,798,873 |
38,883,154 |
RGD:6480464 |
CTD |
| G |
Agfg1 |
ArfGAP with FG repeats 1 |
|
increases expression |
ISO |
9 |
82,162,480 |
82,216,301 |
RGD:6480464 |
CTD |
| G |
Ahctf1 |
AT hook containing transcription factor 1 |
|
multiple interactions |
ISO |
13 |
95,432,560 |
95,483,323 |
RGD:6480464 |
CTD |
| G |
Akt1s1 |
AKT1 substrate 1 (proline-rich) |
|
increases expression |
ISO |
1 |
95,325,272 |
95,328,510 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
decreases expression |
ISO |
10 |
64,308,826 |
64,312,415 |
RGD:6480464 |
CTD |
| G |
Alg9 |
alpha-1,2-mannosyltransferase |
|
multiple interactions |
ISO |
8 |
54,131,722 |
54,194,200 |
RGD:6480464 |
CTD |
| G |
Ankdd1a |
ankyrin repeat and death domain containing 1A |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ankrd44 |
ankyrin repeat domain 44 |
|
increases expression |
ISO |
9 |
53,425,161 |
53,622,961 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
decreases expression |
EXP |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Arf1 |
ADP-ribosylation factor 1 |
|
multiple interactions |
ISO |
10 |
45,516,609 |
45,532,091 |
RGD:6480464 |
CTD |
| G |
Arhgap15 |
Rho GTPase activating protein 15 |
|
increases expression |
ISO |
3 |
24,256,620 |
24,389,618 |
RGD:6480464 |
CTD |
| G |
Asl |
argininosuccinate lyase |
|
decreases expression |
EXP |
12 |
27,702,882 |
27,720,230 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
multiple interactions |
EXP |
4 |
67,117,759 |
67,243,058 |
RGD:6480464 |
CTD |
| G |
C2cd5 |
C2 calcium-dependent domain containing 5 |
|
multiple interactions |
ISO |
4 |
180,903,353 |
180,989,193 |
RGD:6480464 |
CTD |
| G |
C5 |
complement component 5 |
|
multiple interactions |
ISO |
3 |
14,011,115 |
14,102,744 |
RGD:6480464 |
CTD |
| G |
Calu |
calumenin |
|
increases expression |
EXP |
4 |
56,228,617 |
56,256,118 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccdc30 |
coiled-coil domain containing 30 |
|
multiple interactions |
ISO |
5 |
139,915,083 |
139,956,693 |
RGD:6480464 |
CTD |
| G |
Ccdc82 |
coiled-coil domain containing 82 |
|
multiple interactions |
ISO |
8 |
10,118,375 |
10,157,451 |
RGD:6480464 |
CTD |
| G |
Ccdc93 |
coiled-coil domain containing 93 |
|
multiple interactions |
ISO |
13 |
33,465,846 |
33,534,212 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Cd33 |
CD33 molecule |
|
multiple interactions |
ISO |
1 |
93,904,033 |
93,910,383 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd4 |
Cd4 molecule |
|
decreases expression |
ISO |
4 |
160,988,512 |
161,014,038 |
RGD:6480464 |
CTD |
| G |
Cdk13 |
cyclin-dependent kinase 13 |
|
multiple interactions |
ISO |
17 |
55,146,130 |
55,235,545 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
increases expression |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
|
decreases expression |
EXP |
1 |
80,742,540 |
80,758,943 |
RGD:6480464 |
CTD |
| G |
Cep290 |
centrosomal protein 290 |
|
decreases expression |
ISO |
7 |
38,138,545 |
38,228,716 |
RGD:6480464 |
CTD |
| G |
Cep63 |
centrosomal protein 63 |
|
multiple interactions |
ISO |
8 |
107,548,503 |
107,600,193 |
RGD:6480464 |
CTD |
| G |
Cept1 |
choline/ethanolamine phosphotransferase 1 |
|
multiple interactions |
ISO |
2 |
201,801,921 |
201,843,259 |
RGD:6480464 |
CTD |
| G |
Clec16a |
C-type lectin domain family 16, member A |
|
decreases expression |
ISO |
10 |
4,870,719 |
5,069,691 |
RGD:6480464 |
CTD |
| G |
Clec4f |
C-type lectin domain family 4, member F |
|
decreases expression |
ISO |
4 |
117,839,863 |
117,849,584 |
RGD:6480464 |
CTD |
| G |
Clpb |
ClpB caseinolytic peptidase B homolog (E. coli) |
|
multiple interactions |
ISO |
1 |
159,126,512 |
159,246,279 |
RGD:6480464 |
CTD |
| G |
Clpb |
ClpB caseinolytic peptidase B homolog (E. coli) |
|
increases expression |
ISO |
1 |
159,126,512 |
159,246,279 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Coq4 |
coenzyme Q4 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
3 |
8,775,412 |
8,783,745 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
multiple interactions |
ISO |
9 |
35,625,478 |
35,627,304 |
RGD:6480464 |
CTD |
| G |
Cpm |
carboxypeptidase M |
|
multiple interactions |
ISO |
7 |
56,931,920 |
56,992,248 |
RGD:6480464 |
CTD |
| G |
Creld1 |
cysteine-rich with EGF-like domains 1 |
|
multiple interactions |
ISO |
4 |
149,375,373 |
149,384,983 |
RGD:6480464 |
CTD |
| G |
Crtc3 |
CREB regulated transcription coactivator 3 |
|
multiple interactions |
ISO |
1 |
136,763,253 |
136,838,520 |
RGD:6480464 |
CTD |
| G |
Csnk1e |
casein kinase 1, epsilon |
|
multiple interactions |
ISO |
7 |
117,402,718 |
117,420,764 |
RGD:6480464 |
CTD |
| G |
Ctps |
CTP synthase |
|
decreases expression |
ISO |
5 |
141,136,686 |
141,165,817 |
RGD:6480464 |
CTD |
| G |
Ctrl |
chymotrypsin-like |
|
increases expression |
ISO |
19 |
35,774,031 |
35,775,881 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
increases expression |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
decreases expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases metabolic processing |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects hydroxylation |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
decreases expression |
EXP |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects hydroxylation |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
decreases expression |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Dact3 |
dapper, antagonist of beta-catenin, homolog 3 (Xenopus laevis) |
|
multiple interactions |
ISO |
1 |
77,201,808 |
77,213,537 |
RGD:6480464 |
CTD |
| G |
Dcbld1 |
discoidin, CUB and LCCL domain containing 1 |
|
multiple interactions |
ISO |
20 |
30,945,776 |
31,038,692 |
RGD:6480464 |
CTD |
| G |
Ddi2 |
DNA-damage inducible protein 2 |
|
multiple interactions |
ISO |
5 |
160,582,315 |
160,621,531 |
RGD:6480464 |
CTD |
| G |
Dhrs10 |
dehydrogenase/reductase (SDR family) member 10 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dhx8 |
DEAH (Asp-Glu-Ala-His) box polypeptide 8 |
|
multiple interactions |
ISO |
10 |
90,769,567 |
90,806,827 |
RGD:6480464 |
CTD |
| G |
Dlg1 |
discs, large homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
11 |
70,735,283 |
70,930,374 |
RGD:6480464 |
CTD |
| G |
Dnajc15 |
DnaJ (Hsp40) homolog, subfamily C, member 15 |
|
multiple interactions |
ISO |
15 |
58,871,147 |
58,937,853 |
RGD:6480464 |
CTD |
| G |
Dnajc4 |
DnaJ (Hsp40) homolog, subfamily C, member 4 |
|
multiple interactions |
ISO |
1 |
209,661,518 |
209,665,683 |
RGD:6480464 |
CTD |
| G |
Dolk |
dolichol kinase |
|
multiple interactions |
ISO |
3 |
9,329,640 |
9,331,678 |
RGD:6480464 |
CTD |
| G |
Drd5 |
dopamine receptor D5 |
|
increases expression |
ISO |
14 |
77,768,060 |
77,769,487 |
RGD:6480464 |
CTD |
| G |
Dusp19 |
dual specificity phosphatase 19 |
|
multiple interactions |
ISO |
3 |
63,473,333 |
63,485,843 |
RGD:6480464 |
CTD |
| G |
Ears2 |
glutamyl-tRNA synthetase 2, mitochondrial |
|
increases expression |
ISO |
1 |
180,861,635 |
180,889,473 |
RGD:6480464 |
CTD |
| G |
Egln3 |
EGL nine homolog 3 (C. elegans) |
|
multiple interactions |
ISO |
6 |
74,451,038 |
74,476,506 |
RGD:6480464 |
CTD |
| G |
Eif2s3 |
eukaryotic translation initiation factor 2, subunit 3 gamma |
|
increases expression |
ISO |
X |
81,542,853 |
81,566,259 |
RGD:6480464 |
CTD |
| G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
|
increases expression |
ISO |
12 |
14,666,974 |
14,692,130 |
RGD:6480464 |
CTD |
| G |
Eif3e |
eukaryotic translation initiation factor 3, subunit E |
|
decreases expression |
ISO |
7 |
79,013,224 |
79,045,970 |
RGD:6480464 |
CTD |
| G |
Eif4b |
eukaryotic translation initiation factor 4B |
|
increases expression |
ISO |
7 |
140,814,663 |
140,836,485 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
decreases expression |
ISO |
6 |
136,311,381 |
136,318,586 |
RGD:6480464 |
CTD |
| G |
Elp6 |
elongator acetyltransferase complex subunit 6 |
|
multiple interactions |
ISO |
8 |
114,680,298 |
114,695,519 |
RGD:6480464 |
CTD |
| G |
Emc3 |
ER membrane protein complex subunit 3 |
|
multiple interactions |
ISO |
4 |
149,405,742 |
149,422,064 |
RGD:6480464 |
CTD |
| G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
|
multiple interactions |
ISO |
6 |
108,439,822 |
108,469,756 |
RGD:6480464 |
CTD |
| G |
Epg5 |
ectopic P-granules autophagy protein 5 homolog (C. elegans) |
|
multiple interactions |
ISO |
18 |
74,846,785 |
74,942,842 |
RGD:6480464 |
CTD |
| G |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
|
decreases expression |
ISO |
5 |
130,639,805 |
130,739,014 |
RGD:6480464 |
CTD |
| G |
Eps8l1 |
EPS8-like 1 |
|
multiple interactions |
ISO |
1 |
68,072,667 |
68,087,385 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
multiple interactions |
ISO |
9 |
43,248,023 |
43,293,196 |
RGD:6480464 |
CTD |
| G |
Erf |
Ets2 repressor factor |
|
multiple interactions |
ISO |
1 |
80,518,385 |
80,527,142 |
RGD:6480464 |
CTD |
| G |
Ergic1 |
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
|
multiple interactions |
ISO |
10 |
16,793,908 |
16,900,287 |
RGD:6480464 |
CTD |
| G |
Erlin1 |
ER lipid raft associated 1 |
|
multiple interactions |
ISO |
1 |
249,161,437 |
249,196,760 |
RGD:6480464 |
CTD |
| G |
Erlin2 |
ER lipid raft associated 2 |
|
multiple interactions |
ISO |
16 |
69,345,708 |
69,360,849 |
RGD:6480464 |
CTD |
| G |
Exosc3 |
exosome component 3 |
|
multiple interactions |
ISO |
5 |
61,880,622 |
61,883,825 |
RGD:6480464 |
CTD |
| G |
Exosc4 |
exosome component 4 |
|
multiple interactions |
ISO |
7 |
114,374,913 |
114,377,655 |
RGD:6480464 |
CTD |
| G |
Eya3 |
eyes absent homolog 3 (Drosophila) |
|
increases expression |
ISO |
5 |
152,427,552 |
152,507,813 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
increases expression |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fads3 |
fatty acid desaturase 3 |
|
multiple interactions |
ISO |
1 |
212,489,224 |
212,506,444 |
RGD:6480464 |
CTD |
| G |
Falz |
fetal Alzheimer antigen |
|
decreases expression |
ISO |
10 |
96,391,087 |
96,402,832 |
RGD:6480464 |
CTD |
| G |
Fam222b |
family with sequence similarity 222, member B |
|
multiple interactions |
ISO |
10 |
64,478,951 |
64,482,790 |
RGD:6480464 |
CTD |
| G |
Fbxo8 |
F-box protein 8 |
|
multiple interactions |
ISO |
16 |
37,093,835 |
37,139,103 |
RGD:6480464 |
CTD |
| G |
Fchsd2 |
FCH and double SH3 domains 2 |
|
multiple interactions |
ISO |
1 |
158,548,830 |
158,782,422 |
RGD:6480464 |
CTD |
| G |
Fdxr |
ferredoxin reductase |
|
multiple interactions |
ISO |
10 |
105,342,684 |
105,351,374 |
RGD:6480464 |
CTD |
| G |
Fga |
fibrinogen alpha chain |
|
increases expression |
EXP |
2 |
174,737,640 |
174,753,598 |
RGD:6480464 |
CTD |
| G |
Fgb |
fibrinogen beta chain |
|
increases expression |
EXP |
2 |
174,768,193 |
174,775,102 |
RGD:6480464 |
CTD |
| G |
Fhl3 |
four and a half LIM domains 3 |
|
multiple interactions |
ISO |
5 |
144,026,444 |
144,033,195 |
RGD:6480464 |
CTD |
| G |
Fibp |
fibroblast growth factor (acidic) intracellular binding protein |
|
multiple interactions |
ISO |
1 |
208,104,191 |
208,108,458 |
RGD:6480464 |
CTD |
| G |
Fip1l1 |
FIP1 like 1 (S. cerevisiae) |
|
multiple interactions |
ISO |
14 |
35,993,131 |
36,050,974 |
RGD:6480464 |
CTD |
| G |
Fitm2 |
fat storage-inducing transmembrane protein 2 |
|
multiple interactions |
ISO |
3 |
154,375,988 |
154,382,498 |
RGD:6480464 |
CTD |
| G |
Flot2 |
flotillin 2 |
|
multiple interactions |
ISO |
10 |
64,081,463 |
64,104,166 |
RGD:6480464 |
CTD |
| G |
Fnbp4 |
formin binding protein 4 |
|
multiple interactions |
ISO |
3 |
75,111,004 |
75,141,649 |
RGD:6480464 |
CTD |
| G |
Fntb |
farnesyltransferase, CAAX box, beta |
|
multiple interactions |
ISO |
6 |
99,427,967 |
99,511,373 |
RGD:6480464 |
CTD |
| G |
Folr1 |
folate receptor 1 (adult) |
|
multiple interactions |
ISO |
1 |
159,315,191 |
159,324,141 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxk2 |
forkhead box K2 |
|
increases expression |
ISO |
10 |
110,499,723 |
110,551,516 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
GABA(A) receptor-associated protein like 1 |
|
multiple interactions |
ISO |
4 |
166,802,106 |
166,811,249 |
RGD:6480464 |
CTD |
| G |
Gabrr2 |
gamma-aminobutyric acid (GABA) A receptor, rho 2 |
|
multiple interactions |
ISO |
5 |
49,349,963 |
49,387,218 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
increases expression |
EXP |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
multiple interactions |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
|
increases expression |
ISO |
4 |
121,204,274 |
121,250,160 |
RGD:6480464 |
CTD |
| G |
Ggps1 |
geranylgeranyl diphosphate synthase 1 |
|
multiple interactions |
ISO |
17 |
59,458,469 |
59,470,856 |
RGD:6480464 |
CTD |
| G |
Gkap1 |
G kinase anchoring protein 1 |
|
increases expression |
ISO |
17 |
12,315,255 |
12,355,040 |
RGD:6480464 |
CTD |
| G |
Glrx3 |
glutaredoxin 3 |
|
increases expression |
ISO |
1 |
197,176,020 |
197,206,249 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
multiple interactions |
ISO |
9 |
46,380,165 |
46,452,974 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
decreases expression |
EXP |
4 |
12,465,089 |
12,495,028 |
RGD:6480464 |
CTD |
| G |
Gpatch8 |
G patch domain containing 8 |
|
multiple interactions |
ISO |
10 |
91,580,259 |
91,660,338 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
decreases expression |
EXP |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
affects response to substance |
ISO |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hibadh |
3-hydroxyisobutyrate dehydrogenase |
|
decreases expression |
EXP |
4 |
80,850,300 |
80,948,361 |
RGD:6480464 |
CTD |
| G |
Hist1h2ah |
histone cluster 1, H2ah |
|
decreases expression |
ISO |
17 |
48,507,180 |
48,507,572 |
RGD:6480464 |
CTD |
| G |
Idua |
iduronidase, alpha-L- |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ifna1 |
interferon, alpha 1 |
|
decreases metabolic processing |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases secretion |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
multiple interactions |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
decreases expression |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases secretion |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
decreases expression |
ISO |
17 |
78,050,491 |
78,097,802 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases secretion |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
decreases expression |
ISO |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
increases expression |
ISO |
2 |
43,806,301 |
43,842,365 |
RGD:6480464 |
CTD |
| G |
Ilk |
integrin-linked kinase |
|
multiple interactions |
ISO |
1 |
163,481,299 |
163,487,550 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
decreases expression |
ISO |
1 |
201,456,689 |
201,459,756 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
increases expression |
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Itfg1 |
integrin alpha FG-GAP repeat containing 1 |
|
multiple interactions |
ISO |
19 |
22,561,637 |
22,682,885 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
increases expression |
ISO |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itm2b |
integral membrane protein 2B |
|
multiple interactions |
ISO |
15 |
54,005,134 |
54,028,036 |
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
multiple interactions |
ISO |
5 |
121,804,586 |
121,905,581 |
RGD:6480464 |
CTD |
| G |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
|
multiple interactions |
ISO |
1 |
95,066,641 |
95,080,847 |
RGD:6480464 |
CTD |
| G |
Kcnmb4 |
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
|
multiple interactions |
ISO |
7 |
55,751,633 |
55,807,075 |
RGD:6480464 |
CTD |
| G |
Kdm4b |
lysine (K)-specific demethylase 4B |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kif1b |
kinesin family member 1B |
|
multiple interactions |
ISO |
5 |
166,250,225 |
166,381,782 |
RGD:6480464 |
CTD |
| G |
Kin |
antigenic determinant of rec-A protein homolog (mouse) |
|
multiple interactions |
ISO |
17 |
79,728,511 |
79,738,856 |
RGD:6480464 |
CTD |
| G |
Klhl7 |
kelch-like family member 7 |
|
multiple interactions |
ISO |
4 |
6,373,343 |
6,422,371 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
increases expression |
EXP |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Lamc1 |
laminin, gamma 1 |
|
multiple interactions |
ISO |
13 |
68,241,453 |
68,369,419 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
increases expression |
EXP |
3 |
149,016,605 |
149,043,530 |
RGD:6480464 |
CTD |
| G |
Letm2 |
leucine zipper-EF-hand containing transmembrane protein 2 |
|
decreases expression |
ISO |
16 |
70,844,079 |
70,865,537 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lhfp |
lipoma HMGIC fusion partner |
|
multiple interactions |
ISO |
2 |
141,974,792 |
142,183,203 |
RGD:6480464 |
CTD |
| G |
Lhfp |
lipoma HMGIC fusion partner |
|
decreases expression |
ISO |
2 |
141,974,792 |
142,183,203 |
RGD:6480464 |
CTD |
| G |
Limk1 |
LIM domain kinase 1 |
|
multiple interactions |
ISO |
12 |
23,091,809 |
23,125,717 |
RGD:6480464 |
CTD |
| G |
Lipc |
lipase, hepatic |
|
decreases expression |
EXP |
8 |
75,323,442 |
75,450,353 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
multiple interactions |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
increases activity |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
affects localization |
EXP |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
LOC100151767 |
hypothetical LOC100151767 |
|
increases expression |
ISO |
8 |
53,966,678 |
53,977,137 |
RGD:6480464 |
CTD |
| G |
LOC100360447 |
hypothetical protein LOC100360447 |
|
increases expression |
ISO |
1 |
179,509,477 |
179,576,475 |
RGD:6480464 |
CTD |
| G |
LOC100361193 |
tubulin cofactor A |
|
increases expression |
ISO |
7 |
141,657,182 |
141,659,072 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lrrc23 |
leucine rich repeat containing 23 |
|
multiple interactions |
ISO |
4 |
160,899,357 |
160,909,547 |
RGD:6480464 |
CTD |
| G |
Lst1 |
leukocyte specific transcript 1 |
|
increases expression |
ISO |
20 |
3,698,568 |
3,701,564 |
RGD:6480464 |
CTD |
| G |
Ltb |
lymphotoxin beta (TNF superfamily, member 3) |
|
multiple interactions |
ISO |
20 |
3,666,524 |
3,668,369 |
RGD:6480464 |
CTD |
| G |
Ltc4s |
leukotriene C4 synthase |
|
decreases secretion |
ISO |
10 |
35,786,877 |
35,788,838 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
decreases expression |
ISO |
8 |
115,417,764 |
115,440,609 |
RGD:6480464 |
CTD |
| G |
Lyplal1 |
lysophospholipase-like 1 |
|
multiple interactions |
ISO |
13 |
102,143,174 |
102,171,752 |
RGD:6480464 |
CTD |
| G |
Mapk1ip1l |
mitogen-activated protein kinase 1 interacting protein 1-like |
|
multiple interactions |
ISO |
15 |
23,250,737 |
23,274,011 |
RGD:6480464 |
CTD |
| G |
Mapk7 |
mitogen-activated protein kinase 7 |
|
multiple interactions |
ISO |
10 |
47,649,203 |
47,654,316 |
RGD:6480464 |
CTD |
| G |
Mdh1 |
malate dehydrogenase 1, NAD (soluble) |
|
multiple interactions |
ISO |
14 |
102,259,130 |
102,273,788 |
RGD:6480464 |
CTD |
| G |
Med13l |
mediator complex subunit 13-like |
|
multiple interactions |
ISO |
12 |
39,136,265 |
39,181,221 |
RGD:6480464 |
CTD |
| G |
Med16 |
mediator complex subunit 16 |
|
multiple interactions |
ISO |
7 |
11,311,063 |
11,323,562 |
RGD:6480464 |
CTD |
| G |
Mfsd10 |
major facilitator superfamily domain containing 10 |
|
multiple interactions |
ISO |
14 |
81,745,997 |
81,748,824 |
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
multiple interactions |
ISO |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Milr1 |
mast cell immunoglobulin-like receptor 1 |
|
decreases expression |
ISO |
10 |
96,110,944 |
96,111,829 |
RGD:6480464 |
CTD |
| G |
Mlf1ip |
MLF1 interacting protein |
|
multiple interactions |
ISO |
16 |
48,997,465 |
49,020,684 |
RGD:6480464 |
CTD |
| G |
Mon1b |
MON1 homolog b (yeast) |
|
decreases expression |
ISO |
19 |
43,630,351 |
43,637,179 |
RGD:6480464 |
CTD |
| G |
Mphosph6-ps1 |
M phase phosphoprotein 6, pseudogene |
|
multiple interactions |
ISO |
6 |
103,512,896 |
103,513,378 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
decreases expression |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mto1 |
mitochondrial tRNA translation optimization 1 |
|
multiple interactions |
ISO |
8 |
83,444,213 |
83,457,260 |
RGD:6480464 |
CTD |
| G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
decreases expression |
ISO |
1 |
201,962,340 |
201,997,147 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
affects expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myo19 |
myosin XIX |
|
multiple interactions |
ISO |
10 |
73,156,527 |
73,185,812 |
RGD:6480464 |
CTD |
| G |
Mzt1 |
mitotic spindle organizing protein 1 |
|
decreases expression |
ISO |
15 |
82,820,060 |
82,828,971 |
RGD:6480464 |
CTD |
| G |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
|
multiple interactions |
ISO |
12 |
4,184,417 |
4,205,550 |
RGD:6480464 |
CTD |
| G |
Nacc2 |
NACC family member 2, BEN and BTB (POZ) domain containing |
|
increases expression |
ISO |
3 |
4,237,814 |
4,301,608 |
RGD:6480464 |
CTD |
| G |
Napepld |
N-acyl phosphatidylethanolamine phospholipase D |
|
multiple interactions |
ISO |
4 |
8,821,727 |
8,845,709 |
RGD:6480464 |
CTD |
| G |
Narg2 |
NMDA receptor regulated 2 |
|
multiple interactions |
ISO |
8 |
73,836,837 |
73,876,618 |
RGD:6480464 |
CTD |
| G |
Nbeal1 |
neurobeachin-like 1 |
|
multiple interactions |
ISO |
9 |
58,715,343 |
58,887,980 |
RGD:6480464 |
CTD |
| G |
Nck2 |
NCK adaptor protein 2 |
|
multiple interactions |
ISO |
9 |
42,650,261 |
42,776,967 |
RGD:6480464 |
CTD |
| G |
Ndufb2 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 |
|
multiple interactions |
ISO |
4 |
67,099,841 |
67,106,920 |
RGD:6480464 |
CTD |
| G |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
18 |
61,134,242 |
61,477,040 |
RGD:6480464 |
CTD |
| G |
Nlk |
nemo like kinase |
|
multiple interactions |
ISO |
10 |
64,681,240 |
64,804,942 |
RGD:6480464 |
CTD |
| G |
Nnt |
nicotinamide nucleotide transhydrogenase |
|
multiple interactions |
ISO |
2 |
51,496,456 |
51,589,901 |
RGD:6480464 |
CTD |
| G |
Nomo1 |
nodal modulator 1 |
|
affects binding |
ISO |
1 |
96,528,675 |
96,579,476 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nqo2 |
NAD(P)H dehydrogenase, quinone 2 |
|
multiple interactions |
ISO |
17 |
37,255,630 |
37,283,753 |
RGD:6480464 |
CTD |
| G |
Nrxn3 |
neurexin 3 |
|
increases expression |
ISO |
6 |
112,273,955 |
113,905,437 |
RGD:6480464 |
CTD |
| G |
Nsun4 |
NOP2/Sun domain family, member 4 |
|
increases expression |
ISO |
5 |
136,277,224 |
136,297,339 |
RGD:6480464 |
CTD |
| G |
Nts |
neurotensin |
|
multiple interactions |
EXP |
7 |
40,474,654 |
40,484,058 |
RGD:6480464 |
CTD |
| G |
Ociad1 |
OCIA domain containing 1 |
|
multiple interactions |
ISO |
14 |
37,301,310 |
37,318,693 |
RGD:6480464 |
CTD |
| G |
Olr1610 |
olfactory receptor 1610 |
|
increases expression |
ISO |
15 |
26,005,776 |
26,006,702 |
RGD:6480464 |
CTD |
| G |
Osbp |
oxysterol binding protein |
|
increases expression |
ISO |
1 |
214,813,081 |
214,843,558 |
RGD:6480464 |
CTD |
| G |
Otc |
ornithine carbamoyltransferase |
|
decreases expression |
EXP |
X |
24,609,141 |
24,685,341 |
RGD:6480464 |
CTD |
| G |
Otp |
orthopedia homeobox |
|
multiple interactions |
ISO |
2 |
25,176,599 |
25,184,585 |
RGD:6480464 |
CTD |
| G |
Pan3 |
PAN3 polyA specific ribonuclease subunit homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
12 |
8,046,162 |
8,165,081 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
affects binding |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pcp4l1 |
Purkinje cell protein 4-like 1 |
|
multiple interactions |
ISO |
13 |
87,059,476 |
87,083,085 |
RGD:6480464 |
CTD |
| G |
Pcsk5 |
proprotein convertase subtilisin/kexin type 5 |
|
increases expression |
ISO |
1 |
220,961,912 |
221,405,907 |
RGD:6480464 |
CTD |
| G |
Pde3a |
phosphodiesterase 3A, cGMP inhibited |
|
increases expression |
EXP |
4 |
178,658,896 |
178,930,417 |
RGD:6480464 |
CTD |
| G |
Pdss2 |
prenyl (decaprenyl) diphosphate synthase, subunit 2 |
|
multiple interactions |
ISO |
20 |
47,128,350 |
47,359,830 |
RGD:6480464 |
CTD |
| G |
Pea15 |
phosphoprotein enriched in astrocytes 15 |
|
decreases expression |
ISO |
13 |
88,187,674 |
88,197,296 |
RGD:6480464 |
CTD |
| G |
Pex7 |
peroxisomal biogenesis factor 7 |
|
multiple interactions |
ISO |
1 |
15,099,265 |
15,163,734 |
RGD:6480464 |
CTD |
| G |
Phf17 |
PHD finger protein 17 |
|
increases expression |
ISO |
2 |
128,499,983 |
128,553,050 |
RGD:6480464 |
CTD |
| G |
Pias1 |
protein inhibitor of activated STAT, 1 |
|
multiple interactions |
ISO |
8 |
67,025,248 |
67,123,016 |
RGD:6480464 |
CTD |
| G |
Pias2 |
protein inhibitor of activated STAT, 2 |
|
multiple interactions |
ISO |
18 |
74,078,683 |
74,123,668 |
RGD:6480464 |
CTD |
| G |
Picalm |
phosphatidylinositol binding clathrin assembly protein |
|
multiple interactions |
ISO |
1 |
146,754,085 |
146,834,197 |
RGD:6480464 |
CTD |
| G |
Pigc |
phosphatidylinositol glycan anchor biosynthesis, class C |
|
multiple interactions |
ISO |
13 |
77,664,442 |
77,666,797 |
RGD:6480464 |
CTD |
| G |
Pipox |
pipecolic acid oxidase |
|
decreases expression |
ISO |
10 |
63,920,814 |
63,933,307 |
RGD:6480464 |
CTD |
| G |
Pitpnb |
phosphatidylinositol transfer protein, beta |
|
multiple interactions |
ISO |
12 |
45,386,041 |
45,434,744 |
RGD:6480464 |
CTD |
| G |
Pkhd1 |
polycystic kidney and hepatic disease 1 |
|
decreases expression |
ISO |
9 |
18,833,903 |
19,338,716 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
decreases expression |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Plcb1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
|
multiple interactions |
EXP |
3 |
122,797,718 |
123,523,675 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Psmb1 |
proteasome (prosome, macropain) subunit, beta type 1 |
|
affects expression |
EXP |
1 |
54,369,775 |
54,388,816 |
RGD:6480464 |
CTD |
| G |
Psmb10 |
proteasome (prosome, macropain) subunit, beta type 10 |
|
affects expression |
EXP |
19 |
35,777,710 |
35,780,194 |
RGD:6480464 |
CTD |
| G |
Psmb2 |
proteasome (prosome, macropain) subunit, beta type 2 |
|
affects expression |
EXP |
5 |
146,089,234 |
146,121,978 |
RGD:6480464 |
CTD |
| G |
Psmb5 |
proteasome (prosome, macropain) subunit, beta type 5 |
|
affects expression |
EXP |
15 |
32,689,859 |
32,694,364 |
RGD:6480464 |
CTD |
| G |
Psmb8 |
proteasome (prosome, macropain) subunit, beta type, 8 |
|
affects expression |
EXP |
20 |
4,786,260 |
4,789,223 |
RGD:6480464 |
CTD |
| G |
Psmb9 |
proteasome (prosome, macropain) subunit, beta type, 9 |
|
affects expression |
EXP |
20 |
4,801,187 |
4,806,608 |
RGD:6480464 |
CTD |
| G |
Ptma |
prothymosin alpha |
|
decreases expression |
EXP |
9 |
85,291,203 |
85,295,242 |
RGD:6480464 |
CTD |
| G |
Rad9a |
RAD9 homolog A (S. pombe) |
|
decreases expression |
ISO |
1 |
206,778,534 |
206,785,230 |
RGD:6480464 |
CTD |
| G |
Rc3h1 |
ring finger and CCCH-type domains 1 |
|
multiple interactions |
ISO |
13 |
76,493,343 |
76,530,107 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
affects expression |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
RGD1307325 |
similar to RIKEN cDNA 4933411K20 |
|
increases expression |
ISO |
16 |
49,366,648 |
49,404,995 |
RGD:6480464 |
CTD |
| G |
Ric3 |
resistance to inhibitors of cholinesterase 3 homolog (C. elegans) |
|
affects binding |
ISO |
1 |
166,608,198 |
166,660,309 |
RGD:6480464 |
CTD |
| G |
Riok3 |
RIO kinase 3 |
|
decreases expression |
ISO |
18 |
3,672,960 |
3,698,533 |
RGD:6480464 |
CTD |
| G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
|
multiple interactions |
ISO |
15 |
33,947,406 |
33,956,351 |
RGD:6480464 |
CTD |
| G |
Rmnd5a |
required for meiotic nuclear division 5 homolog A (S. cerevisiae) |
|
multiple interactions |
ISO |
4 |
104,603,984 |
104,657,016 |
RGD:6480464 |
CTD |
| G |
Rps15 |
ribosomal protein S15 |
|
decreases expression |
ISO |
7 |
10,927,341 |
10,928,780 |
RGD:6480464 |
CTD |
| G |
Sbspon |
somatomedin B and thrombospondin, type 1 domain containing |
|
decreases expression |
ISO |
5 |
2,516,220 |
2,547,152 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
increases expression |
ISO |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Secisbp2 |
SECIS binding protein 2 |
|
multiple interactions |
ISO |
17 |
19,391,401 |
19,422,392 |
RGD:6480464 |
CTD |
| G |
Sell |
selectin L |
|
multiple interactions |
ISO |
13 |
79,827,342 |
79,845,296 |
RGD:6480464 |
CTD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
affects response to substance |
ISO |
6 |
127,998,617 |
128,021,719 |
RGD:6480464 |
CTD |
| G |
Setd2 |
SET domain containing 2 |
|
decreases expression |
ISO |
8 |
114,913,851 |
114,999,955 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
multiple interactions |
ISO |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sh2d2a |
SH2 domain containing 2A |
|
multiple interactions |
ISO |
2 |
179,916,108 |
179,924,623 |
RGD:6480464 |
CTD |
| G |
Sh3rf1 |
SH3 domain containing ring finger 1 |
|
multiple interactions |
ISO |
16 |
32,054,773 |
32,215,987 |
RGD:6480464 |
CTD |
| G |
Shprh |
SNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
1 |
5,846,062 |
5,922,176 |
RGD:6480464 |
CTD |
| G |
Sirt2 |
sirtuin 2 |
|
multiple interactions |
ISO |
1 |
83,873,578 |
83,896,121 |
RGD:6480464 |
CTD |
| G |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
|
multiple interactions |
ISO |
11 |
68,934,104 |
69,087,168 |
RGD:6480464 |
CTD |
| G |
Slc12a9 |
solute carrier family 12 (potassium/chloride transporters), member 9 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
multiple interactions |
ISO |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc25a24 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24 |
|
multiple interactions |
ISO |
2 |
204,721,524 |
204,760,766 |
RGD:6480464 |
CTD |
| G |
Slc39a9 |
solute carrier family 39 (zinc transporter), member 9 |
|
increases expression |
ISO |
6 |
104,407,151 |
104,442,633 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases expression |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
increases expression |
EXP |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slmap |
sarcolemma associated protein |
|
multiple interactions |
ISO |
16 |
1,707,264 |
1,822,281 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
multiple interactions |
ISO |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Smad5 |
SMAD family member 5 |
|
multiple interactions |
ISO |
17 |
13,814,164 |
13,824,358 |
RGD:6480464 |
CTD |
| G |
Smek2 |
SMEK homolog 2, suppressor of mek1 (Dictyostelium) |
|
multiple interactions |
ISO |
14 |
110,170,267 |
110,219,298 |
RGD:6480464 |
CTD |
| G |
Smu1 |
smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans) |
|
increases expression |
ISO |
5 |
58,115,070 |
58,133,640 |
RGD:6480464 |
CTD |
| G |
Snap23 |
synaptosomal-associated protein 23 |
|
multiple interactions |
ISO |
3 |
107,361,066 |
107,362,878 |
RGD:6480464 |
CTD |
| G |
Snx13 |
sorting nexin 13 |
|
multiple interactions |
ISO |
6 |
53,727,055 |
53,827,207 |
RGD:6480464 |
CTD |
| G |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
|
decreases expression |
ISO |
9 |
56,584,578 |
56,607,773 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
decreases expression |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srr |
serine racemase |
|
decreases expression |
ISO |
10 |
62,217,481 |
62,234,831 |
RGD:6480464 |
CTD |
| G |
Ssr1 |
signal sequence receptor, alpha |
|
decreases expression |
ISO |
17 |
33,061,975 |
33,077,827 |
RGD:6480464 |
CTD |
| G |
Ssr3 |
signal sequence receptor, gamma |
|
increases expression |
ISO |
2 |
155,147,350 |
155,156,029 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
increases secretion |
ISO |
11 |
79,125,031 |
79,126,216 |
RGD:6480464 |
CTD |
| G |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
|
multiple interactions |
ISO |
5 |
138,397,472 |
138,599,287 |
RGD:6480464 |
CTD |
| G |
Stam2 |
signal transducing adaptor molecule (SH3 domain and ITAM motif) 2 |
|
multiple interactions |
ISO |
3 |
34,213,013 |
34,259,375 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stk24 |
serine/threonine kinase 24 |
|
multiple interactions |
ISO |
15 |
106,256,862 |
106,307,134 |
RGD:6480464 |
CTD |
| G |
Stk35 |
serine/threonine kinase 35 |
|
multiple interactions |
ISO |
3 |
117,407,255 |
117,435,699 |
RGD:6480464 |
CTD |
| G |
Supt6h |
suppressor of Ty 6 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
10 |
64,388,961 |
64,425,858 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
ISO |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Taf1a |
TATA box binding protein (Tbp)-associated factor, RNA polymerase I, A |
|
increases expression |
ISO |
13 |
99,475,709 |
99,484,662 |
RGD:6480464 |
CTD |
| G |
Taf7 |
TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
decreases expression |
ISO |
18 |
30,541,432 |
30,543,580 |
RGD:6480464 |
CTD |
| G |
Tars2 |
threonyl-tRNA synthetase 2, mitochondrial (putative) |
|
multiple interactions |
ISO |
2 |
190,530,782 |
190,547,829 |
RGD:6480464 |
CTD |
| G |
Tas2r140 |
taste receptor, type 2, member 140 |
|
multiple interactions |
ISO |
4 |
170,271,493 |
170,272,431 |
RGD:6480464 |
CTD |
| G |
Tbca |
tubulin folding cofactor A |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tbxas1 |
thromboxane A synthase 1, platelet |
|
multiple interactions |
ISO |
4 |
66,502,253 |
66,677,538 |
RGD:6480464 |
CTD |
| G |
Tcf3 |
transcription factor 3 |
|
multiple interactions |
ISO |
7 |
10,791,311 |
10,813,613 |
RGD:6480464 |
CTD |
| G |
Tcn2 |
transcobalamin 2 |
|
increases expression |
ISO |
14 |
84,579,191 |
84,593,641 |
RGD:6480464 |
CTD |
| G |
Tefm |
transcription elongation factor, mitochondrial |
|
multiple interactions |
ISO |
10 |
68,341,244 |
68,345,583 |
RGD:6480464 |
CTD |
| G |
Tesk1 |
testis-specific kinase 1 |
|
increases expression |
ISO |
5 |
59,913,793 |
59,918,422 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgif1 |
TGFB-induced factor homeobox 1 |
|
increases expression |
ISO |
9 |
110,043,164 |
110,052,783 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
decreases expression |
EXP |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Tmc5 |
transmembrane channel-like 5 |
|
multiple interactions |
ISO |
1 |
176,854,487 |
176,865,156 |
RGD:6480464 |
CTD |
| G |
Tmed4 |
transmembrane emp24 protein transport domain containing 4 |
|
multiple interactions |
ISO |
14 |
86,997,282 |
87,001,869 |
RGD:6480464 |
CTD |
| G |
Tmem106b |
transmembrane protein 106B |
|
multiple interactions |
ISO |
4 |
38,398,245 |
38,415,059 |
RGD:6480464 |
CTD |
| G |
Tmem19 |
transmembrane protein 19 |
|
decreases expression |
ISO |
7 |
54,606,463 |
54,632,803 |
RGD:6480464 |
CTD |
| G |
Tmem63a |
transmembrane protein 63a |
|
decreases expression |
ISO |
13 |
96,671,527 |
96,704,177 |
RGD:6480464 |
CTD |
| G |
Tmem80 |
transmembrane protein 80 |
|
multiple interactions |
ISO |
1 |
201,524,983 |
201,533,592 |
RGD:6480464 |
CTD |
| G |
Tmem87b |
transmembrane protein 87B |
|
multiple interactions |
ISO |
3 |
116,433,488 |
116,466,218 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
|
multiple interactions |
ISO |
18 |
45,083,452 |
45,126,709 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpmt |
thiopurine S-methyltransferase |
|
increases expression |
ISO |
17 |
23,697,900 |
23,714,173 |
RGD:6480464 |
CTD |
| G |
Tpp2 |
tripeptidyl peptidase II |
|
multiple interactions |
ISO |
9 |
42,984,834 |
43,066,195 |
RGD:6480464 |
CTD |
| G |
Trmt13 |
tRNA methyltransferase 13 homolog (S. cerevisiae) |
|
increases expression |
ISO |
2 |
212,812,720 |
212,825,603 |
RGD:6480464 |
CTD |
| G |
Trmt61a |
tRNA methyltransferase 61 homolog A (S. cerevisiae) |
|
multiple interactions |
ISO |
6 |
136,460,061 |
136,466,051 |
RGD:6480464 |
CTD |
| G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
|
multiple interactions |
ISO |
3 |
114,320,799 |
114,410,498 |
RGD:6480464 |
CTD |
| G |
Ttc3 |
tetratricopeptide repeat domain 3 |
|
multiple interactions |
ISO |
11 |
34,617,072 |
34,659,043 |
RGD:6480464 |
CTD |
| G |
Ttc37 |
tetratricopeptide repeat domain 37 |
|
decreases expression |
ISO |
2 |
3,196,865 |
3,307,075 |
RGD:6480464 |
CTD |
| G |
Ttll3 |
tubulin tyrosine ligase-like family, member 3 |
|
affects binding |
ISO |
4 |
149,280,690 |
149,282,413 |
RGD:6480464 |
CTD |
| G |
Tuba1b |
tubulin, alpha 1B |
|
multiple interactions |
ISO |
7 |
137,706,858 |
137,709,839 |
RGD:6480464 |
CTD |
| G |
Tubd1 |
tubulin, delta 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tusc3 |
tumor suppressor candidate 3 |
|
increases expression |
ISO |
16 |
56,760,904 |
56,929,685 |
RGD:6480464 |
CTD |
| G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
|
affects expression |
EXP |
X |
12,926,049 |
12,944,522 |
RGD:6480464 |
CTD |
| G |
Ube2d3 |
ubiquitin-conjugating enzyme E2D 3 |
|
affects expression |
EXP |
2 |
232,943,214 |
232,971,022 |
RGD:6480464 |
CTD |
| G |
Ubfd1 |
ubiquitin family domain containing 1 |
|
multiple interactions |
ISO |
1 |
180,889,833 |
180,901,230 |
RGD:6480464 |
CTD |
| G |
Ubqln2 |
ubiquilin 2 |
|
increases expression |
ISO |
X |
37,992,907 |
37,996,327 |
RGD:6480464 |
CTD |
| G |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
|
multiple interactions |
ISO |
10 |
91,385,368 |
91,398,458 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
affects expression |
EXP |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Ufm1 |
ubiquitin-fold modifier 1 |
|
multiple interactions |
ISO |
2 |
143,057,364 |
143,064,329 |
RGD:6480464 |
CTD |
| G |
Ugt2b35 |
UDP glucuronosyltransferase 2 family, polypeptide B35 |
|
decreases expression |
ISO |
14 |
22,454,256 |
22,493,510 |
RGD:6480464 |
CTD |
| G |
Utp15 |
UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae) |
|
increases expression |
ISO |
2 |
28,837,115 |
28,853,532 |
RGD:6480464 |
CTD |
| G |
Wdr20 |
WD repeat domain 20 |
|
multiple interactions |
ISO |
6 |
135,460,172 |
135,529,326 |
RGD:6480464 |
CTD |
| G |
Wtap |
Wilms tumor 1 associated protein |
|
multiple interactions |
ISO |
1 |
41,891,437 |
41,917,254 |
RGD:6480464 |
CTD |
Term paths to the root
|